![]() GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ![]() Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | ||
Founding Date | Founding Date 1990 | Founding Date 2012 | Founding Date 1983 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ |
Employees | Employees 387 | Employees 352106% increase | Employees 20333% decrease |
Valuation ($) | Valuation ($) 697 m | Valuation ($) 4.4 b | Valuation ($) 268.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $154.9m (FY, 2025) |
Cost of goods | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $3.3m (FY, 2021) | Cost of goods $41.3m (FY, 2025) |
Gross profit | Gross profit ¥24b (FY, 2025) | Gross profit N/A | Gross profit $113.6m (FY, 2025) |
Net income | Net income (¥12.5b) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income ($20.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 65m | Total funding raised $ 88.7m | Total funding raised N/A |

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company